References in periodicals archive ?
GlobalData, the industry analysis specialist, has released its new report, Amyotrophic Lateral Sclerosis (ALS) - Pipeline Assessment and Market Forecasts to 2017.
Companies Involved in Amyotrophic Lateral Sclerosis Therapeutics Development
EpiCast Report: Amyotrophic Lateral Sclerosis - Epidemiology Forecast to 2023 http://www.
Unaccomplished Trials of Amyotrophic Lateral Sclerosis 25
Identify and understand important and diverse types of therapeutics under development for Amyotrophic Lateral Sclerosis.
She was not immunosuppressed but was debilitated by amyotrophic lateral sclerosis.
Fore Pharma's latest report 'Global Amyotrophic Lateral Sclerosis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Amyotrophic Lateral Sclerosis market.
Develop business strategies by understanding the trends shaping and driving the global Amyotrophic Lateral Sclerosis Therapeutics market.
Scope The report analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal trends in Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington's Disease (HD).
Prions are now thought to be the possible causes of degenerative brain diseases, such as Alzheimer's disease, multiple sclerosis (MS), Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy.
Three months later, Vaughan and his wife, Shelly, were told the speech difficulty was an early symptom of amyotrophic lateral sclerosis - a brain disorder that slowly robs sufferers of their speech and movement and is usually fatal within five years of diagnosis.